Metabolomics pilot study to identify volatile organic compound markers of childhood asthma in exhaled breath

Bioanalysis

Volumn 5, Issue 18, 2013, Pages 2239-2247

  Gahleitner, Florian ^a   Guallar Hoyas, Cristina ^b   Beardsmore, Caroline S ^a   Pandya, Hitesh C ^a   Thomas, Cl Paul ^b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b LOUGHBOROUGH UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 (METHYLSULFANYL)PROPANE; 1 ISOPROPYL 3 METHYLBENZENE; 1,4 DICHLOROBENZENE; 1,7 DIMETHYLNAPHTALENE; 2 OCTENAL; ETHYLBENZENE; LIMONENE; OCTADECYNE; ORGANIC COMPOUND; UNCLASSIFIED DRUG; VOLATILE ORGANIC COMPOUND; BIOLOGICAL MARKER;

ADOLESCENT; ARTICLE; ASTHMA; BREATH ANALYSIS; CHEMICAL ANALYSIS; CHILD; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HYDROPHOBICITY; MALE; MASS FRAGMENTOGRAPHY; METABOLOMICS; OUTCOME ASSESSMENT; PILOT STUDY; PREDICTION; SCHOOL CHILD; SEPARATION TECHNIQUE; SYNDROME DELINEATION; WORKFLOW; EXHALATION; METABOLISM; PRINCIPAL COMPONENT ANALYSIS;

ASTHMA; BIOLOGICAL MARKERS; BREATH TESTS; CHILD; EXHALATION; FEMALE; HUMANS; MALE; METABOLOMICS; PILOT PROJECTS; PRINCIPAL COMPONENT ANALYSIS; VOLATILE ORGANIC COMPOUNDS;

EID: 84885011607     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.13.184     Document Type: Article

References (25)

1. British Guideline on the Management of Asthma. Thorax 63(Suppl. 4:iv), 1-121 (2008).
2. Amann A, Smith D. Breath Analysis for Clinical Diagnosis and Therapeutic Monitoring. World Scientific Publishing, Singapore (2005).
3. Van Berkel JJBN, Dallinga JW, Möller GM et al. Development of accurate classification method based on the analysis of volatile organic compounds from human exhaled air. J. Chromatogr. B 861(1), 101-107 (2008).
4. Guallar-Hoyas C, Turner MA, Blackburn GJ, Wilson ID, Thomas, CLP. A workflow for the metabolomic/metabonomic investigation of exhaled breath using thermal desorption GC-MS. Bioanalysis 4(18), 2227-2237 (2012).
5. Directive 2004/42/CE of the European Parliament and of the Council on the limitation of emissions of volatile organic compounds due to the use of organic solvents in certain paints and varnishes and vehicle refinishing products and amending Directive 1999/13/EC., L 143. Sect. 87 (2004).
6. Phillips M, Herrera J, Krishnan S, Zain M, Greenberg J, Cataneo RN. Variation in volatile organic compounds in the breath of normal humans. J. Chromatogr. B Biomed. Sci. Appl. 729(1-2), 75-88 (1999).
7. Barker M, Hengst M, Schmid J et al. Volatile organic compounds in the exhaled breath of young patients with cystic fibrosis. Eur. Respir. J. 27(5), 929-936 (2006).
8. Robroeks CM, van Berkel JJ, Dallinga JW et al. Metabolomics of volatile organic compounds in cystic fibrosis patients and controls. Pediatr. Res. 68(1), 75-80 (2010).
9. Fens N, Zwinderman AH, van der Schee MP et al. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. Am. J. Respir. Crit. Care Med. 180(11), 1076-1082 (2009).
10. Dragonieri S, Schot R, Mertens BJ et al. An electronic nose in the discrimination of patients with asthma and controls. J. Allergy Clin. Immunol. 120 (4), 856-862 (2007).
11. Dallinga JW, Robroeks CM, van Berkel JJ et al. Volatile organic compounds in exhaled breath as a diagnostic tool for asthma in children. Clin. Exp. Allergy 40(1), 68-76 (2010).
12. Delfino RJ, Gong H, Linn WS, Hu Y, Pellizzari ED. Respiratory symptoms and peak expiratory flow in children with asthma in relation to volatile organic compounds in exhaled breath and ambient air. J. Expo. Anal. Environ. Epidemiol. 13(5), 348-363 (2003).
13. Ibrahim B, Basanta M, Cadden P et al. Non-invasive phenotyping using exhaled volatile organic compounds in asthma. Thorax 66(9), 804-809 (2011).
14. Novak BJ, Blake DR, Meinardi S et al. Exhaled methyl nitrate as a non-invasive marker of hyperglycaemia in type 1 diabetes. Proc. Natl Acad. Sci. USA 104(40), 15613-15618 (2007).
15. Gahleitner F, Guallar-Hoyas C, Blackburn G et al. Towards a metabolomic approach to respiratory disease in childhood: feasibility and acceptability of a novel breath-sampling procedure and initial chemical breath analysis. Thorax 64(Suppl. IV), A18 (2009).
16. Basanta M, Koimtzis T, Singh D, Wilson I, Thomas CLP. An adaptive breath sampler for use with human subjects with an impaired respiratory function. Analyst. 132(2), 153-163 (2007).
17. Hoffmann E de, Stroobant V. Mass Spectrometry: Principles and Applications (3rd Edition). John Wiley & Sons, Ltd, NJ, USA (2007).
18. Basanta M, Jarvis RM, Xu Y et al. Non-invasive metabolomic analysis of breath using differential mobility spectrometry in patients with chronic obstructive pulmonary disease and healthy smokers. Analyst 135(2), 315-320 (2010).
19. Elliott L, Longnecker MP, Kissling GE, London SJ. Volatile organic compounds and pulmonary function in the Third National Health and Nutrition Examination Survey, 1988-1994. Environ. Health Perspect. 114(8), 1210-1214 (2006).
20. Rumchev K, Spickett J, Bulsara M, Phillips M, Stick S. Association of domestic exposure to volatile organic compounds with asthma in young children. Thorax 59(9), 746-751 (2004).
21. Guarneri F, Barbuzza O, Vaccaro M, Galtieri G. Allergic contact dermatitis and asthma caused by limonene in a labourer handling citrus fruits. Contact Dermatitis 58(5), 315-316 (2008).
22. Wainman T, Zhang J, Weschler CJ, Lioy PJ. Ozone and limonene in indoor air: a source of submicron particle exposure. Environ. Health Perspect. 108(12), 1139-1145 (2000).
23. Thomas CE, Jackson RL, Ohlweiler DF, Ku G. Multiple lipid oxidation products in low density lipoproteins induce interleukin-1 b release from human blood mononuclear cells. J. Lipid Res. 35(3), 417-427 (1994).
24. Phillips M, Basa-Dalay V. Blais J et al. Point-of-care breath test for biomarkers of active pulmonary tuberculosis. Tuberculosis (Edinb.). 92(4) 314-320 (2012).
25. Metabolomics pilot study to identify markers of childhood asthma | Research Article